Acquired Bleeding Disorder (DBCOND0030736)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01153997	Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers	Catridecacog	treatment	1	completed
NCT00127283	Recombinant Factor VIIa in Acute Intracerebral Haemorrhage	Coagulation factor VIIa Recombinant Human	treatment	3	completed
NCT00124293	Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury	Coagulation factor VII human	Not Available	Not Available	completed
NCT00323570	Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma	Coagulation factor VII human	treatment	3	withdrawn
NCT01601613	Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever	Coagulation factor VII human Coagulation factor VIIa Recombinant Human	treatment	2	completed
NCT01563458	Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation	Coagulation factor VII human	treatment	2	completed
NCT01564563	Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation	Coagulation factor VII human	treatment	2	terminated
NCT00184548	Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding	Coagulation factor VIIa Recombinant Human	treatment	3	terminated
NCT01601457	Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction	Coagulation factor VII human	treatment	2	completed
NCT00697320	Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany	Coagulation factor VII human Coagulation factor VIIa Recombinant Human	Not Available	Not Available	completed
NCT00154427	Use of Activated Recombinant Human Factor VII in Cardiac Surgery	Coagulation factor VII human	treatment	2	terminated
NCT00914589	Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery	Catridecacog	prevention	2	completed
NCT02239146	Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass	Catridecacog	treatment	1	completed
NCT00426803	Recombinant Factor VIIa in Acute Intracerebral Haemorrhage	Coagulation factor VII human	treatment	2	completed
NCT01562821	Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy	Coagulation factor VII human	treatment	2	completed
NCT01563445	Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth in Acute Intracerebral Haemorrhage	Coagulation factor VII human	treatment	2	completed
NCT00102037	Use of Activated Recombinant FVII in Spinal Surgery	Coagulation factor VII human Coagulation factor VIIa Recombinant Human	treatment	2	completed
NCT00266006	Factor VIIa in Acute Intracerebral Haemorrhage	Coagulation factor VII human Coagulation factor VIIa Recombinant Human	treatment	2	completed
NCT01561417	Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects	Coagulation factor VII human	treatment	1	completed
NCT01562158	Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation	Coagulation factor VII human	treatment	2	completed
NCT01566786	Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage	Coagulation factor VII human	treatment	2	completed
NCT01562574	Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease	Coagulation factor VII human	treatment	3	completed
NCT00123591	Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury	Coagulation factor VII human	treatment	2	completed
NCT01285089	Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia	Coagulation factor VII human	Not Available	Not Available	completed
NCT00154492	Use of NovoSeven® in Active Variceal Bleeding	Coagulation factor VII human	treatment	2	completed
NCT01563523	Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients	Coagulation factor VII human	treatment	2	completed